Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 Other Infectious Disease POC
1.3 Market by Application
1.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Perspective (2018-2033)
2.2 Point-of-Care Infectious Disease Diagnostics & Testing Growth Trends by Region
2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Region (2018-2023)
2.2.3 Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2024-2033)
2.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Dynamics
2.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Trends
2.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
2.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
2.3.4 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue (2018-2023)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Players (2018-2023)
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics & Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2022
3.5 Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Area Served
3.6 Key Players Point-of-Care Infectious Disease Diagnostics & Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Type (2018-2023)
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2024-2033)
5 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Application
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Application (2018-2023)
5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2033)
6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023)
6.4 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2033)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023)
7.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2033)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2033)
9.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023)
9.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2018-2033)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Detail
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.3.4 Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Detail
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Detail
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Detail
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Detail
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Detail
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Detail
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
11.11.1 bioMérieux SA Company Detail
11.11.2 bioMérieux SA Business Overview
11.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
11.12.1 Sight Diagnostics Ltd. Company Detail
11.12.2 Sight Diagnostics Ltd. Business Overview
11.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
11.13.1 Gene POC Company Detail
11.13.2 Gene POC Business Overview
11.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Detail
11.14.2 Trivitron Healthcare Business Overview
11.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
11.15.1 OJ-Bio Ltd. Company Detail
11.15.2 OJ-Bio Ltd. Business Overview
11.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Detail
11.16.2 Ortho-Clinical Diagnostics Business Overview
11.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
11.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of HIV POC
Table 3. Key Players of Clostridium difficile POC
Table 4. Key Players of HBV POC
Table 5. Key Players of Pneumonia or Streptococcus associated infections
Table 6. Key Players of Respiratory syncytial virus (RSV) POC
Table 7. Key Players of HPV POC
Table 8. Key Players of Influenza/Flu POC
Table 9. Key Players of Other Infectious Disease POC
Table 10. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2018-2023)
Table 14. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2024-2033)
Table 16. Point-of-Care Infectious Disease Diagnostics & Testing Market Trends
Table 17. Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
Table 18. Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
Table 19. Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
Table 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Players (2018-2023)
Table 22. Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2022)
Table 23. Ranking of Global Top Point-of-Care Infectious Disease Diagnostics & Testing Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Point-of-Care Infectious Disease Diagnostics & Testing Product Solution and Service
Table 27. Date of Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type (2018-2023)
Table 31. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type (2024-2033)
Table 33. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Application (2018-2023)
Table 35. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Application (2024-2033)
Table 37. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2024-2033) & (US$ Million)
Table 52. Abbott Company Detail
Table 53. Abbott Business Overview
Table 54. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 55. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Thermo Fisher Scientific Inc Company Detail
Table 58. Thermo Fisher Scientific Inc Business Overview
Table 59. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 60. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 61. Thermo Fisher Scientific Inc Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 65. Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Siemens Healthineers Company Detail
Table 68. Siemens Healthineers Business Overview
Table 69. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 70. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 71. Siemens Healthineers Recent Development
Table 72. BD & Company Company Detail
Table 73. BD & Company Business Overview
Table 74. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 75. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 76. BD & Company Recent Development
Table 77. Chembio Diagnostics Inc. Company Detail
Table 78. Chembio Diagnostics Inc. Business Overview
Table 79. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 80. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 81. Chembio Diagnostics Inc. Recent Development
Table 82. Trinity Biotech Company Detail
Table 83. Trinity Biotech Business Overview
Table 84. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 85. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 86. Trinity Biotech Recent Development
Table 87. Cardinal Health Company Detail
Table 88. Cardinal Health Business Overview
Table 89. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 90. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 91. Cardinal Health Recent Development
Table 92. Quest Diagnostics Inc. Company Detail
Table 93. Quest Diagnostics Inc. Business Overview
Table 94. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 95. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 96. Quest Diagnostics Inc. Recent Development
Table 97. Bio-Rad Labs Inc. Company Detail
Table 98. Bio-Rad Labs Inc. Business Overview
Table 99. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 100. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 101. Bio-Rad Labs Inc. Recent Development
Table 102. bioMérieux SA Company Detail
Table 103. bioMérieux SA Business Overview
Table 104. bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 105. bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 106. bioMérieux SA Recent Development
Table 107. Sight Diagnostics Ltd. Company Detail
Table 108. Sight Diagnostics Ltd. Business Overview
Table 109. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 110. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 111. Sight Diagnostics Ltd. Recent Development
Table 112. Gene POC Company Detail
Table 113. Gene POC Business Overview
Table 114. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 115. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 116. Gene POC Recent Development
Table 117. Trivitron Healthcare Company Detail
Table 118. Trivitron Healthcare Business Overview
Table 119. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 120. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 121. Trivitron Healthcare Recent Development
Table 122. OJ-Bio Ltd. Company Detail
Table 123. OJ-Bio Ltd. Business Overview
Table 124. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 125. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 126. OJ-Bio Ltd. Recent Development
Table 127. Ortho-Clinical Diagnostics Company Detail
Table 128. Ortho-Clinical Diagnostics Business Overview
Table 129. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 130. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023) & (US$ Million)
Table 131. Ortho-Clinical Diagnostics Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type: 2022 VS 2033
Figure 3. HIV POC Features
Figure 4. Clostridium difficile POC Features
Figure 5. HBV POC Features
Figure 6. Pneumonia or Streptococcus associated infections Features
Figure 7. Respiratory syncytial virus (RSV) POC Features
Figure 8. HPV POC Features
Figure 9. Influenza/Flu POC Features
Figure 10. Other Infectious Disease POC Features
Figure 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application: 2022 VS 2033
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Home Case Studies
Figure 16. Assisted Living Healthcare Facilities Case Studies
Figure 17. Laboratories Case Studies
Figure 18. Others Case Studies
Figure 19. Point-of-Care Infectious Disease Diagnostics & Testing Report Years Considered
Figure 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 22. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region: 2022 VS 2033
Figure 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Players in 2022
Figure 24. Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2022
Figure 26. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2018-2033)
Figure 28. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2018-2033)
Figure 32. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2018-2033)
Figure 40. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2018-2033)
Figure 48. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2018-2033)
Figure 52. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 55. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 56. Roche Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 57. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 58. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 59. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 60. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 61. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 62. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 63. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 64. bioMérieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 65. Sight Diagnostics Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 66. Gene POC Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 67. Trivitron Healthcare Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 68. OJ-Bio Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 69. Ortho-Clinical Diagnostics Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed